Skip to main content

Advertisement

Log in

Minimally invasive surgical staging for esophageal cancer

  • Original Articles
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background: The incidence of esophageal adenocarcinoma is increasing in the United States, and the 5-year survival rate is dismal. Preliminary data suggest that conventional imaging is inaccurate in staging esophageal cancer and could limit accurate assessment of new treatments. The objective of this study was to compare minimally invasive surgical staging (MIS) with conventional imaging for staging esophageal cancer.

Methods: Patients with potentially resectable esophageal cancer were eligible. Staging by conventional methods used computed tomography (CT) scan of the chest and abdomen, and endoscopic ultrasound (EUS), whereas MIS used laparoscopy and videothoracoscopy. Conventional staging results were compared to those from MIS.

Results: In 53 patients, the following stages were assigned by CT scan and EUS: carcinoma in situ (CIS; n=1), I (n=1), II (n=23), III (n=20), IV (n=8). In 17 patients (32.1%), MIS demonstrated inaccuracies in the conventional imaging, reassigning a lower stage in 10 patients and a more advanced stage in 7 patients.

Conclusions: In 32.1% of patients with esophageal cancer, MIS changed the stage originally assigned by CT scan and EUS. Therefore, MIS should be applied to evaluate the accuracy of new noninvasive imaging methods and to assess new therapies for esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ajani J (1998) Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus. Chest 113: 112S-119S

    Article  PubMed  CAS  Google Scholar 

  2. Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, Siegel BA, Cooper JD (1997) Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64: 770–776

    Article  PubMed  CAS  Google Scholar 

  3. Blot WJ, Devesa SS, Fraumeni JF Jr (1993) Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 270: 1320

    Article  PubMed  CAS  Google Scholar 

  4. Krasna MJ, Flowers JL, Attar S, McLaughlin J (1996) Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg 111: 800–807

    Article  PubMed  CAS  Google Scholar 

  5. Krasna MJ, Reed CE, Jaklitsch MT, Cushing D, Sugarbaker DJ, Cancer and Leukemia Group B Thoracic Surgeons (1995) Thoracoscopic staging of esophageal cancer: a prospective, multi-institutional trial. Ann Thorac Surg 60: 1337–1340

    Article  PubMed  CAS  Google Scholar 

  6. Luketich JD, Friedman DM, Weigel TL, Meehan MA, Keenan RJ, Townsend DW, Meltzer CC (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive scans. Ann Thorac Surg 68: 1133–1137

    Article  PubMed  CAS  Google Scholar 

  7. Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, Yousem SA, Siegfried JM (1998) Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 66: 1715–1718

    Article  PubMed  CAS  Google Scholar 

  8. Luketich JD, Schauer P, Landreneau R, Nguyen N, Urso K, Ferson P, Keenan R, Kim R (1997) Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 114: 817–823

    Article  PubMed  CAS  Google Scholar 

  9. Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP (1997) Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64: 765–769

    Article  PubMed  CAS  Google Scholar 

  10. Luketich JD, Schauer P, Urso K, Kassis E, Ferson P, Keenan R, Landreneau R (1998) Future direction in esophageal cancer. Chest 113: 120S-122S

    Article  PubMed  CAS  Google Scholar 

  11. Luketich JD, van Raemdonck DE, Ginsberg RJ (1993) Extended resection for higher-stage non-small cell lung cancer. World J Surg 17: 719–728

    Article  PubMed  CAS  Google Scholar 

  12. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK eds. (1999) SEER cancer statistics review, 1973–1996. Betheseda, MD: National Cancer Institute

    Google Scholar 

  13. Tamim WZ, Davidson RS, Quinlan RM, O’Shea MA, Orr RK, Swanson RS (1998) Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile? Arch Surg 133: 722–726

    Article  PubMed  CAS  Google Scholar 

  14. Zaccaro G, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, Gitlin L, Adelstein DJ (1999) Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94: 906–912

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Online publication: 12 July 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luketich, J.D., Median, M., Nguyen, N.T. et al. Minimally invasive surgical staging for esophageal cancer. Surg Endosc 14, 700–702 (2000). https://doi.org/10.1007/s004640000222

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004640000222

Key words

Navigation